Why After Fully Covid-19 Vaccinated, We are Still Obliged to Implement Health Protocols: An Evidence-Based on Agent-Based Simulation
Downloads
Background: The current outbreak of COVID-19 affected many countries in the world, including Indonesia. The Indonesian government has taken various actions to prevent the spread of COVID-19. One of them is by applying the 3M health protocols (wearing masks, washing hands, and maintaining distance). Considering that vaccines are a critical tool in the battle against COVID-19, the Indonesian government began the COVID-19 Vaccination program on January 13, 2021. Unfortunately, many people believe that the vaccines can fully protect against COVID-19 so they are not applying the 3M health protocols anymore. Admittedly the efficiency of vaccines is not completely protective, the virus itself is still mutating and even can spread more massively. Several simulations of the spread of COVID-19 have been carried out by several researchers. However, only a few research has included variables about compliance with health protocols and vaccine programs. Objective: This study aims to provide empirical evidence for health promotion by showing why after fully COVID-19 vaccinated, people are still obliged to implement health protocols. Methods: We conducted 12 scenarios of simulations to understand the effect of complying and not complying with these two programs. Results: The simulation results show that after being fully vaccinated against COVID-19, it is proven that people are still required to implement health protocols such as wearing masks, washing hands, and practicing physical and social distancing because there is still the possibility of contracting the COVID-19 virus and spreading the virus. Conclusion: Our simulation results provide empirical evidence for health promotion by showing why after fully COVID-19 vaccinated, people are still obliged to implement health protocols. This can be evidence for the government and related agencies to educate the public to be more compliant in implementing health protocols so that we can hope that no one will be infected with the COVID-19 virus and everyone can return to their normal activities
Badan Pengawas Obat dan Makanan - Republik Indonesia (2022) Penerbitan Persetujuan Penggunaan Dalam Kondisi Darurat Atau Emergency Use Authorization (EUA) Pertama Untuk Vaksin COVID-19.
Billari, F. C. et al. (2006) ‘Agent-based computational modelling: An introduction’, Contributions to Economics, pp. 1–16. doi: 10.1007/3-7908-1721-X_1/COVER.
Bonabeau, E. (2002) ‘Agent-based modeling: Methods and techniques for simulating human systems’, Proceedings of the National Academy of Sciences of the United States of America, 99(SUPPL. 3), pp. 7280–7287. doi: 10.1073/PNAS.082080899/ASSET/15AB2074-4729-491A-B9E6-292A9C40AE31/ASSETS/GRAPHIC/PQ0820808004.JPEG.
Center for Disease Control and Prevention (2022) How to Protect Yourself & Others.
Chang, S. L. et al. (2020) ‘Modelling transmission and control of the COVID-19 pandemic in Australia’, Nature Communications 2020 11:1, 11(1), pp. 1–13. doi: 10.1038/s41467-020-19393-6.
Currie, C. S. M. et al. (2020) ‘How simulation modelling can help reduce the impact of COVID-19’, https://doi.org/10.1080/17477778.2020.1751570, 14(2), pp. 83–97. doi: 10.1080/17477778.2020.1751570.
Epstein, J. M. (2009) ‘Modelling to contain pandemics’, Nature 2009 460:7256, 460(7256), pp. 687–687. doi: 10.1038/460687a.
Hanly, M. et al. (2022) ‘Vaccinating Australia: How long will it take?’, Vaccine, 40(17), pp. 2491–2497. doi: 10.1016/J.VACCINE.2021.07.006.
Hanly, M. J. et al. (2022) ‘The impact of re-opening the international border on COVID-19 hospitalisations in Australia: a modelling study’, Medical Journal of Australia, 216(1), pp. 39–42. doi: 10.5694/MJA2.51291.
Kementrian Kesehatan RI (2021) Program Vaksinasi COVID-19 Mulai Dilakukan, Presiden Orang Pertama Penerima Suntikan Vaksin COVID-19 – P2P Kemenkes RI.
Kementrian Kesehatan RI (2022) SIRANAP.
Li, J. and Giabbanelli, P. (2021) ‘Returning to a Normal Life via COVID-19 Vaccines in the United States: A Large-scale Agent-Based Simulation Study’, JMIR Med Inform 2021;9(4):e27419 https://medinform.jmir.org/2021/4/e27419, 9(4), p. e27419. doi: 10.2196/27419.
Long, Q. X. et al. (2020) ‘Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections’, Nature Medicine 2020 26:8, 26(8), pp. 1200–1204. doi: 10.1038/s41591-020-0965-6.
MacAl, C. M. and North, M. J. (2017) ‘Tutorial on agent-based modelling and simulation’, https://doi.org/10.1057/jos.2010.3, 4(3), pp. 151–162. doi: 10.1057/JOS.2010.3.
Maghfiroh, L. R. and Siagian, T. H. (2020) ‘SIMULASI BERBASIS AGEN UNTUK MENGEVALUASI PENYEBARAN COVID-19 DI INDONESIA’, Seminar Nasional Official Statistics, 2020(1), pp. 124–131. doi: 10.34123/SEMNASOFFSTAT.V2020I1.616.
Mancuso, M., Eikenberry, S. E. and Gumel, A. B. (2021) ‘Will vaccine-derived protective immunity curtail COVID-19 variants in the US?’, Infectious Disease Modelling, 6, pp. 1110–1134. doi: 10.1016/J.IDM.2021.08.008.
McDonald, I. et al. (2021) ‘Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2’, npj Vaccines 2021 6:1, 6(1), pp. 1–14. doi: 10.1038/s41541-021-00336-1.
Pan, H. et al. (2021) ‘Immunogenicity and safety of a third dose, and immune persistence of CoronaVac vaccine in healthy adults aged 18-59 years: interim results from a double-blind, randomized, placebo-controlled phase 2 clinical trial’, medRxiv, p. 2021.07.23.21261026. doi: 10.1101/2021.07.23.21261026.
Rotshild, V. et al. (2021) ‘Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis’, Scientific Reports 2021 11:1, 11(1), pp. 1–9. doi: 10.1038/s41598-021-02321-z.
Satuan Tugas Penanganan COVID-19 (2020) Pedoman Pencegahan dan Pengendalian CORONAVIRUS DISEASE (COVID-19) Revisi ke-5 - Protokol | Covid19.go.id.
Satuan Tugas Penanganan COVID-19 (2022) Tanya Jawab | Covid19.go.id.
Stokes, E. K. et al. (2022) ‘Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020’, MMWR. Morbidity and Mortality Weekly Report, 69(24), pp. 759–765. doi: 10.15585/MMWR.MM6924E2.
Valdez, A. C. (2020) ‘NetLogo Web: infections’.
Wilensky, U. (1999) The CCL.
World Health Organization (2020) Media Statement: Knowing the risks for COVID-19.
World Health Organization (2021) Episode #49 - Can I get infected after vaccination?
World Health Organization (2022a) Advice for the public.
World Health Organization (2022b) Coronavirus disease (COVID-19): Vaccines.
World Health Organization (2022c) COVID-19 after Vaccination: Possible Breakthrough Infection.
World Health Organization (2022d) Pertanyaan jawaban terkait COVID-19 untuk publik.
Yang, C. & Wilensky, U. (2011) NetLogo Models Library: epiDEM Travel and Control.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
In order to be accepted and published by Jurnal Promkes: The Indonesian Journal of Health Promotion and Health Education, Author(s) who submit an article should complete all the review process. The copyright of received articles assigned to the Jurnal Promkes: The Indonesian Journal of Health Promotion and Health Education,and Department of Health Promotion and Behavior Science, Universitas Airlangga as publishers of the journal. The intended copyright includes the rights to publish articles in various forms (including reprints).
Jurnal Promkes: The Indonesian Journal of Health Promotion and Health Education's website. Authors are allowed to use their works for any purposes deemed necessary without written permission from Jurnal Promkes: The Indonesian Journal of Health Promotion and Health EducationS and/or Department of Health Promotion and Behavior Science, Universitas Airlangga with an acknowledgement of initial publication in this journal.
The Editorial Team of Jurnal Promkes: The Indonesian Journal of Health Promotion and Health Education and Department of Health Promotion and Behavior Sciences strive to ensure that no errors occur in the articles that have been published, both data errors and statements in the article.
Users of this website will be licensed to use materials from this website following the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. No fees charged. Please use the materials accordingly.
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
